|
DK455088D0
(da)
|
1988-08-12 |
1988-08-12 |
Symbicom Ab |
Syntetiske receptoranaloger
|
|
CA2106301C
(en)
|
1991-03-18 |
1999-04-06 |
Chi-Huey Wong |
Oligosaccharide enzyme substrates and inhibitors: method and compositions
|
|
US5620864A
(en)
|
1992-06-29 |
1997-04-15 |
Health Research, Inc. |
Acceptor for fucosyl transferase
|
|
DK76193D0
(da)
|
1993-06-25 |
1993-06-25 |
Astra Ab |
Kulhydratderivater
|
|
DE19643764A1
(de)
|
1996-09-30 |
1998-04-02 |
Bayer Ag |
Glycokonjugate von modifizierten Camptothecin-Derivaten (20-0-Verknüpfung)
|
|
DE19654180A1
(de)
|
1996-12-23 |
1998-06-25 |
Hoechst Ag |
Phosphane, Verfahren zu ihrer Herstellung und ihre Verwendung in Metallkomplexen
|
|
US6323176B1
(en)
|
1998-02-25 |
2001-11-27 |
Eli Lilly And Company |
Cyclic peptide antifungal agents
|
|
WO2000035945A1
(en)
|
1998-12-16 |
2000-06-22 |
Eli Lilly And Company |
Cyclic peptide antifungal agents having a sugar substituent
|
|
SE0100172D0
(sv)
|
2001-01-22 |
2001-01-22 |
Ulf Nilsson |
New inhibitors against galectins
|
|
FR2835527B1
(fr)
|
2002-02-05 |
2004-03-12 |
Centre Nat Rech Scient |
Synthese de molecules de type inositolphosphate glycanne: traitement des troubles de la proliferation cellulaire et des desordres metaboliques caracterises par une resistance a l'insuline
|
|
AUPS213802A0
(en)
|
2002-05-03 |
2002-06-06 |
Alchemia Pty Ltd |
Disaccharides for drug discovery
|
|
CA2528152A1
(en)
|
2003-06-03 |
2005-01-06 |
The Regents Of The University Of California |
Compositions and methods for treatment of disease with acetylated disaccharides
|
|
WO2005061523A1
(en)
|
2003-12-23 |
2005-07-07 |
Progen Industries Limited |
Glycosaminoglycan (gag) mimetics
|
|
SE0401300D0
(sv)
|
2004-05-21 |
2004-05-21 |
Forskarpatent I Syd Ab |
Novel Galactoside Inhibitors of Galectins
|
|
SE0401301D0
(sv)
|
2004-05-21 |
2004-05-21 |
Forskarpatent I Syd Ab |
Novel 3-triazolyl-galactoside inhibitors of galectins
|
|
EP1632498A1
(en)
|
2004-09-03 |
2006-03-08 |
Syngenta Participations AG |
Derivatives of avermectin, avermectin monosaccharide and avermectin aglycone
|
|
WO2007021721A2
(en)
|
2005-08-09 |
2007-02-22 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
|
|
US20090214439A1
(en)
|
2006-03-15 |
2009-08-27 |
Trustees Of Tufts College |
Fluorinated Carbohydrates and Their Use in Tumor Visualization, Tissue Engineering, and Cancer Chemotherapy
|
|
US20090176717A1
(en)
|
2006-06-01 |
2009-07-09 |
Glycomimetics, Inc. |
Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
EP1964846A1
(en)
|
2007-02-27 |
2008-09-03 |
Bracco Imaging, S.P.A. |
Process for the preparation of contrast agents
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
KR102085687B1
(ko)
|
2008-04-08 |
2020-03-06 |
슬로안-케테링인스티튜트퍼캔서리서치 |
트리테르펜 사포닌, 그의 합성 방법, 및 그의 용도
|
|
US8697862B2
(en)
|
2008-05-16 |
2014-04-15 |
Galecto Biotech Ab |
Synthesis of galactoside inhibitors
|
|
US9220767B2
(en)
|
2008-10-08 |
2015-12-29 |
Abivax |
Vaccine composition for use against influenza
|
|
ES2652488T3
(es)
|
2009-04-28 |
2018-02-02 |
Galecto Biotech Ab |
Nuevos inhibidores de galactósidos de galectinas
|
|
WO2011002673A1
(en)
|
2009-07-01 |
2011-01-06 |
Temple University - Of The Commonwealth System Of Higher Education |
Leptin agonist and methods of use
|
|
US9624255B2
(en)
|
2009-08-11 |
2017-04-18 |
Arizona Board Of Regents |
Carbohydrate-mediated tumor targeting
|
|
WO2011129314A1
(ja)
|
2010-04-13 |
2011-10-20 |
和光純薬工業株式会社 |
糖類の重水素化方法
|
|
US9243021B2
(en)
|
2012-10-31 |
2016-01-26 |
Galecto Biotech Ab |
Galactoside inhibitor of galectins
|
|
EP2620443A1
(en)
|
2012-01-25 |
2013-07-31 |
Galecto Biotech AB |
Novel galactoside inhibitors of galectins
|
|
WO2013170985A1
(en)
|
2012-05-18 |
2013-11-21 |
Boettger Erik C |
New aminoglycoside antibiotics targeting bacterial 16s ribosomal rna lacking ototoxicity
|
|
EP2859112A4
(en)
|
2012-06-08 |
2015-10-28 |
Glycom As |
PROCESS FOR THE PREPARATION OF OLIGOSACCHARIDES AND OLIGOSACCHARIDE GLYCOSIDES BY FERMENTATION
|
|
GB201214736D0
(en)
|
2012-08-17 |
2012-10-03 |
Isis Innovation |
Inflammation imaging and therapy
|
|
HRP20180268T4
(hr)
|
2012-10-23 |
2026-03-27 |
Synaffix B.V. |
Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu
|
|
IN2015DN02573A
(cg-RX-API-DMAC7.html)
|
2012-10-31 |
2015-09-11 |
Galecto Biotech Ab |
|
|
EP2919802A4
(en)
|
2012-11-15 |
2016-09-14 |
Univ Tufts |
METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER
|
|
GB2511137A
(en)
|
2013-02-26 |
2014-08-27 |
Glykos Finland Oy |
Chelator Molecule
|
|
AU2014236356A1
(en)
|
2013-03-14 |
2015-09-24 |
The Regents Of The University Of California |
Thiosaccharide mucolytic agents
|
|
DK2991683T3
(da)
|
2013-05-02 |
2019-11-04 |
Glykos Finland Oy |
Konjugater af et glykoprotein eller en glykan med en toksisk ladning
|
|
US20170095496A1
(en)
|
2014-04-08 |
2017-04-06 |
Galecto Biotech Ab |
Galactoside inhibitors for new uses
|
|
FR3020952B1
(fr)
|
2014-05-14 |
2017-09-08 |
Adocia |
Formulation a action rapide d'insuline comprenant un compose anionique substitue et un compose polyanionique
|
|
WO2015197082A1
(en)
|
2014-06-27 |
2015-12-30 |
Glycom A/S |
Oligosaccharide production
|
|
JP6735680B2
(ja)
|
2014-07-09 |
2020-08-05 |
ガレクト バイオテック エービー |
ガレクチンの新規ハイブリッドガラクトシド阻害剤
|
|
US20170274087A1
(en)
|
2014-09-19 |
2017-09-28 |
Emory University |
Saccharide analogs and agents for the diagnosis and therapy of bacterial infections
|
|
WO2016113335A1
(en)
|
2015-01-16 |
2016-07-21 |
Galecto Biotech Ab |
Novel galactoside inhibitor of galectins
|
|
CA2970062C
(en)
*
|
2015-01-30 |
2023-02-28 |
Galecto Biotech Ab |
Alpha-d-galactoside inhibitors of galectins
|
|
US11406655B2
(en)
|
2015-05-12 |
2022-08-09 |
Galecto Biotech Ab |
Once-daily treatment of pulmonary fibrosis
|
|
US10799522B2
(en)
|
2015-07-27 |
2020-10-13 |
Wayne State University |
Compositions and methods relating to galectin detection
|
|
CA3000924A1
(en)
|
2015-11-09 |
2017-05-18 |
Galecto Biotech Ab |
Novel galactoside inhibitors of galectins
|
|
CN109563119A
(zh)
*
|
2016-07-12 |
2019-04-02 |
格莱克特生物技术公司 |
半乳糖凝集素的α-D-半乳糖苷抑制剂
|
|
KR102626669B1
(ko)
|
2017-05-12 |
2024-01-17 |
갈랙틴 사이언시즈, 엘엘씨 |
질환의 예방 및 치료를 위한 화합물 및 이의 용도
|
|
CA3062649A1
(en)
|
2017-05-12 |
2018-11-15 |
Galectin Sciences, Llc |
Compounds for the treatment of systemic insulin resistance disorders and the use thereof
|
|
US11267811B2
(en)
|
2017-09-27 |
2022-03-08 |
Bristol-Myers Squibb Company |
Small molecule inhibitors of galectin-3
|
|
WO2019075045A1
(en)
|
2017-10-11 |
2019-04-18 |
Bristol-Myers Squibb Company |
INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
|
|
US11548908B2
(en)
|
2017-12-29 |
2023-01-10 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
|
JP7547345B2
(ja)
|
2018-12-27 |
2024-09-09 |
グリコミメティクス, インコーポレイテッド |
ガレクチン-3阻害性c-グリコシド
|
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
|
CA3136661A1
(en)
|
2019-04-24 |
2020-10-29 |
Glycomimetics, Inc. |
Galactose-linked multimeric glycomimetic inhibitors of e-selectins, galectin-3, and/or cxcr4 chemokine receptors
|
|
WO2021086816A1
(en)
|
2019-10-29 |
2021-05-06 |
Glycomimetics, Inc. |
Galectin-3 inhibiting c-glycosides
|